Company Filing History:
1 out of 9 
1 out of 8 
Years Active: 2012
Title: The Innovations of Won Man Park
Introduction
Won Man Park is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of renal cell carcinoma. His work has led to the development of innovative diagnostic tools that can aid in the early detection of this type of cancer.
Latest Patents
Won Man Park holds a patent for a diagnostic composition and kit for renal cell carcinoma. This patent discloses a composition and kit that utilize various markers, including nicotinamide N-methyltransferase, L-plastin, secretagogin, NM23A, CapG, and C4a anaphylatoxin, to diagnose renal cell carcinoma effectively. This innovation represents a significant advancement in cancer diagnostics.
Career Highlights
Throughout his career, Won Man Park has worked with several companies, including DCD Inc. and Genomine, Inc. His experience in these organizations has contributed to his expertise in developing diagnostic solutions for medical applications.
Collaborations
Won Man Park has collaborated with notable individuals in his field, including Dong Su Kim and Nam Hoon Cho. These collaborations have likely enhanced his research and development efforts in medical diagnostics.
Conclusion
Won Man Park's contributions to the field of medical diagnostics, particularly through his patent for renal cell carcinoma detection, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the medical community positively.